Clinical trial Recruiting at 4 sites Observational

Long-term recovery and vaccination cost-effectiveness for tick-borne encephalitis in the Czech Republic

Official title: Clinical and Public-Health Impact of Tick-Borne Encephalitis: A Prospective Multicenter Observational Study With 12-Month Follow-up and Cost-Effectiveness Analysis

Run by Charles University, Czech Republic · NCT07274046 · Data updated 2026-11-12

This project follows children and adults hospitalized with tick-borne encephalitis in the Czech Republic to see how they recover, which symptoms persist, and to estimate the health and economic benefits of vaccination.

More Tick Borne Encephalitis (TBE) trials

Quick facts

Study typeObservational
SexAll
Enrollment209 (estimated)
SponsorCharles University, Czech Republic
Academic / other
Locations4 sites (Ostrava, Moravian-Silesian Region and 3 other locations)
StatusRecruiting
StartedApril 1, 2023
Main results expectedDecember 2025
Study endsDecember 2026
Registry record updatedDecember 10, 2025
Trial IDNCT07274046 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are children or adults hospitalized with laboratory-confirmed TBE who can provide informed consent (or have a legal guardian provide consent) and can attend or be contacted for scheduled follow-up assessments.

Probably not a fit

Patients without laboratory confirmation of TBE, those with an alternative diagnosis explaining their neurological symptoms, or those unable to complete follow-up are unlikely to gain direct benefit from the study's clinical or policy findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective multicenter observational study enrolling children and adults hospitalized with laboratory-confirmed TBE across major Czech infectious disease centers. Participants receive standardized clinical, functional, and quality-of-life assessments at discharge and at 2–4 weeks, 3 months, 6 months, and 12 months to map recovery trajectories and identify persistent symptoms characterized as post-encephalitic syndrome. Acute disease severity is categorized using predefined clinical criteria including paresis, ICU admission, prolonged hospitalization, or death. The dataset is combined with health-economic analyses to model the potential population-level impact and cost-effectiveness of broader TBE vaccination in this high-incidence setting.

Why it matters

Potential benefit: If successful, the findings could improve post-TBE follow-up and rehabilitation and inform vaccination policies that reduce future cases and long-term disability.

How similar studies have gone: Previous cohort studies have documented persistent post-encephalitic symptoms and economic models have supported TBE vaccination in some settings, but large prospective multicenter data linking clinical sequelae and cost-effectiveness in a high-incidence country remain relatively limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Hospitalization due to suspected central nervous system (CNS) infection.
* Laboratory-confirmed TBE, defined as:

the presence of CNS symptoms and cerebrospinal fluid pleocytosis (\>5 × 10⁶/L) and TBEV IgM and IgG seropositivity in serum, or detection of TBEV IgM in CSF in previously vaccinated individuals.

* All age groups (children and adults).
* Ability to participate in scheduled follow-up (in person or via telephone).
* Informed consent provided by the patient or legal guardian (for minors).

Exclusion Criteria:

* Alternative diagnosis explaining the CNS symptoms
* Missing essential clinical or laboratory data required to confirm TBE or assess outcomes.
* Refusal or inability to provide informed consent.
* Inability to complete follow-up assessments, including situations where reliable contact cannot be maintained.
* Coexisting severe neurological disorder unrelated to TBE that prevents meaningful evaluation of sequelae (e.g., advanced neurodegenerative disease, severe preexisting motor disability).

Where it's running

  • Ostrava University Hospital
    Ostrava, Moravian-Silesian Region, Czechia
    Recruiting
  • Pardubická nemocnice
    Pardubice, Pardubice Region, Czechia
    Recruiting
  • Bulovka University Hospital
    Prague, Prague, Czechia
    Recruiting
  • České Budějovice Hospital
    České Budějovice, South Bohemian Region, Czechia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.